Effects of 3-(2-Hydroxyphenyl)-1-(5-methyl-furan-2-y-l) propenone (HMP) upon signalling pathways of lipopolysaccharide-induced iNOS synthesis in RAW 264.7 cells

International Immunopharmacology

Volumn 11, Issue 1, 2011, Pages 85-95

  Liew, Choi Yi ^a   Lam, Kok Wai ^a   Kim, Min Kyu ^a,b   Harith, Hanis H ^a   Tham, Chau Ling ^a   Cheah, Yoke Kqueen ^a   Sulaiman, Mohd Roslan ^a   Lajis, Nordin H ^a   Israf, Daud A ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b Korea Foundation of Polytechnic Colleges   (South Korea)

Author keywords

Hydroxypropenone; iNOS; MAPK; NF B; Nitric oxide

Indexed keywords

3 (2 HYDROXYPHENYL) 1 (5 METHYL FURAN 2 Y L)PROPENONE; ACTIVATING TRANSCRIPTION FACTOR 2; CHALCONE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; NITRIC OXIDE; STAT1 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL LINE; DNA BINDING; DRUG EFFECT; ENZYME ACTIVITY; MACROPHAGE; MOLECULAR DOCKING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME INDUCTION; FURANS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MOLECULAR STRUCTURE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PROPIOPHENONES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 78651413980     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.10.011     Document Type: Article

References (60)

1. S.S. Makarov NF-κB as a therapeutic target in chronic inflammation: recent advances Mol Med Tod 6 2000 441 448
2. A. Abate, S. Oberle, and H. Schroder Lipopolysaccharide-induced expression of cyclooxygenase-2 in mouse macrophages is inhibited by chloromethylketones and a direct inhibitor of NF-κB translocation Prostag Oth Lipid M 56 1998 277 290
3. M.P. Pando, and I.M. Verma Signal-dependent and -independent degradation of free and NF-κB-bound I-κBα J Biol Chem 275 2000 21278 21286
4. P. Dell'Albani, R. Santangelo, L. Torrisi, V.G. Nicoletti, and J. de Vellis Giuffrida Stella, A.M. JAK/STAT signaling pathway mediates cytokine-induced iNOS expression in primary astroglial cell cultures J Neurosci Res 65 2001 417 424
5. W. Liu, M. Kato, M. Itoigawa, H. Murakami, M. Yajima, and J. Wu Distinct involvement of NF-κB and p38 mitogen-activated protein kinase pathways in serum deprivation-mediated stimulation of inducible nitric oxide synthase and its inhibition by 4-hydroxynonenal J Cell Biochem 83 2001 271 280
6. C. Tan, A. Mui, and S. Dedhar Integrin-linked kinase regulates inducible nitric oxide synthase and cyclooxygenase-2 expression in an NF-κB- dependent manner J Biol Chem 277 2002 3109 3116
7. T. Matsuguchi, A. Masuda, K. Sugimoto, Y. Nagai, and Y. Yoshikai JNK-interacting protein 3 associates with Toll-like receptor 4 and is involved in LPS-mediated JNK activation EMBO J 22 2003 4455
8. Y. Kim, H.J. Kim, H. Park, and H.P. Kim Anti-inflammatory Activity of the Synthetic Chalcone Derivatives: Inhibition of Inducible Nitric Oxide Synthase-Catalyzed Nitric Oxide Production from Lipopolysaccharide-Treated RAW 264.7 Cells Biol Pharm Bull 30 2007 1450 1455
9. E.D. Chan, and D.W. Riches IFN-gamma + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38(mapk) in a mouse macrophage cell line Am J Physiol Cell Physiol 280 2001 441 450
10. E. Herlaar, and Z. Brown p38 MAPK signaling cascades in inflammatory disease Mol Med Today 5 1999 439 447
11. S.J. Ajizian, B.K. English, and E.A. Meals Specific inhibitors of p38 and Erk pathways block iNOS and TNF-α accumulation in murine macrophages stimulated with LPS and IFN-γ J Inf Dis 179 1999 939 944
12. Y.J. Jeon, S.B. Han, K.S. Ahn, and H.M. Kim Activation of NF-κB/ Rel in Angelan-stimulated macrophages Immunopharmacology 43 1999 1 9
13. E. Shaulian, and M. Karin AP-1 as a regulator of cell life and death Nat Cell Biol 4 2002 E131 E136
14. M. Karin, Z. Liu, and E. Zandi AP-1 function and regulation Curr Opin Cell Biol 9 1997 940-246
15. M. Lin, L. Tsao, L. Chang, Y. Chen, L. Huang, and S. Kuo Inhibition of lipopolysaccharide-stimulated NO production by a novel synthetic compound CYL-4d in RAW264.7 macrophages involving the blockade of MEK4/JNK/AP-1 pathway Biochem Pharmacol 73 2007 1796 1806
16. Y. Nasuhara, I.M. Adcock, M. Catley, P.J. Barnes, and R. Newton Differential IκB kinase activation and I-κBα degradation by interleukin-1β and tumor necrosis factor-α in human U937 monocytic cells J Biol Chem 274 1999 19965 19972
17. J.M. Griscavage, S. Wilk, and L.J. Ignarro Inhibitors of the proteasomes pathway interfere with induction of nitric oxide synthase in macrophage by blocking activation of transcription factor NF-κB Proc Natl Acad Sci USA 93 1996 3308 3312
18. A.K. Kiemer, T. Hartung, C. Huber, and A. Vollmar Phyllanthus amarus has anti-inflammatory potential by inhibition of iNOS, COX-2, and cytokines via the NF-κB pathway J Hepatol 38 2003 289 297
19. Y.W. Lee, S.H. Han, M. Lee, K.H. Yang, H.M. Kim, and Y.J. Jeon 2-Amino-3-methylimidazo[4, 5-f]quinoline inhibits nitric oxide production in lipopolysaccharide-stimulated RAW264 7 cells by blocking p38 kinase activation Cancer Lett 156 2000 133 139
20. H. Kleinert, A. Pautz, K. Linker, and P.M. Schwarz Regulation of the expression of inducible nitric oxide synthase Eur J Pharmacol 500 2004 255 266
21. R. Korhonen, A. Lahti, M. Hamalainen, H. Kankaanranta, and E. Moilanen Dexamethasone inhibits inducible nitric-oxide synthase expression and nitric oxide production by destabilizing mRNA in lipopolysaccharide-treated macrophages Mol Pharmacol 62 2002 698 704
22. H.J. Kim, K. Tsoyi, J.M. Heo, Y.J. Kang, M.K. Park, and Y.S. Lee Regulation of Lipopolysaccharide-Induced Inducible Nitric-Oxide Synthase Expression through the Nuclear Factor-κB Pathway and Interferon-β/ Tyrosine Kinase 2/Janus Tyrosine Kinase 2-Signal Transducer and Activator of Transcription-1 Signaling Cascades by 2-Naphthylethyl-6,7-dihydroxy-1,2,3,4- tetrahydroisoquinoline (THI 53), a New Synthetic Isoquinoline Alkaloid J Pharmacol Exp Ther 320 2007 782 789
23. W.J. Leonard, and J.J. O'Shea Jaks and STATs: biological implications Ann Rev Immunol 16 1998 293 322
24. O. Sareila, M. Hamalainen, E. Nissinen, H. Kankaanranta, and E. Moilanen Orazipone Inhibits Activation of Inflammatory Transcription Factors Nuclear Factor-κB and Signal Transducer and Activator of Transcription 1 and Decreases Inducible Nitric-Oxide Synthase Expression and Nitric Oxide Production in Response to Inflammatory Stimuli J Pharmacol Exp Ther 324 2008 858 866
25. T. Salonen, O. Sareila, U. Jalonen, H. Kankaanranta, R. Tuominen, and E. Moilanen Inhibition of classical PKC isoenzymes downregulates STAT1 activation and iNOS expression in LPS-treated murine J774 macrophages Br J Pharmacol 147 2006 790 799
26. M.T. Cruz, C.B. Duarte, M. Goncalo, A.P. Carvalho, and M.C. Lopes Involvement of JAK2 and MAPK on type II nitric oxide synthase expression in skin-derived dendritic cells Am J Physiol Cell Physiol 277 1999 C1050 C1057
27. M.T. Cruz, C.B. Duarte, M. Goncalo, A.P. Carvalho, and M.C. Lopes LPS induction of IκB-α degradation and iNOS expression in a skin dendritic cell line is prevented by the janus kinase 2 inhibitor, Tyrphostin b42 Nit Ox 5 2001 53 61
28. J.E. Durbin, R. Hackenmiller, M.C. Simon, and D.E. Levy Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease Cell 84 1996 443 450
29. M.A. Meraz Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway Cell 84 1996 431 442
30. T. Kisseleva, S. Bhattacharya, J. Braunstein, and C.W. Schindler Signaling through the JAK/STAT pathway, recent advances and future challenges Gene 285 2002 1 24
31. J.J. Gao, D.C. Morrison, T.J. Parmely, S.W. Russell, and W.J. Murphy An Interferon-γ-activated Site (GAS) Is Necessary for Full Expression of the Mouse iNOS Gene in Response to Interferon-γ and Lipopolysaccharide J Biol Chem 272 1997 1226 1230
32. D.A. Israf, T.A. Khaizurin, A. Syahida, N.H. Lajis, and S. Khozirah Cardamonin inhibits COX and iNOS expression via inhibition of p65NF-kappaB nuclear translocation and Ikappa-B phosphorylation in RAW 264.7 macrophage cells Mol Immunol 44 2007 673 679
33. A. Syahida, D.A. Israf, N.H. Lajis, K. Shaari, H. Mohamed, and A.A. Wahab Cardamonin, inhibits pro-inflammatory mediators in activated RAW 264.7 cells and whole blood Euro J Pharmacol 538 2006 188 194
34. F. Herencia, M.L. Ferrandiz, A. Ubeda, I. Guillen, J.N. Dominguez, and J.E. Charris Novel anti-inflammatory chalcone derivatives inhibit the induction of nitric oxide synthase and cyclooxygenase- 2 in mouse peritoneal macrophages FEBS Lett 453 1999 129 134
35. Z.J. Cheng, C.N. Lin, T.L. Hwang, and C.M. Teng Broussochalcone A, a potent antioxidant and effective suppressor of inducible nitric oxide synthase in lipopolysaccharide-activated macrophages Biochem Pharmacol 61 2001 939 946
36. H.S. Ban, K. Suzuki, S.S. Lim, S.H. Jung, S. Lee, and J. Ji Inhibition of lipopolysaccharide-induced expression of inducible nitric oxide synthase and tumor necrosis factor-a by 2′-hydroxychalcone derivatives in RAW 264.7 cells Biochem Pharmacol 67 2004 1549 1557
37. Y.C. Huang, J.H. Guh, Z.J. Cheng, Y.L. Chang, T.L. Hwang, and C.N. Lin Inhibitory effect of DCDC on lipopolysaccharide-induced nitric oxide synthesis in RAW 264.7 cells Life Sci 68 2001 2435 2447
38. 2 and proinflammatory cytokine synthesis Immunopharmacol Immunotoxicol 32 2010 495 506
39. W.V. Berghe, S. Plaisance, E. Boone, K. De Bosscher, M. Lienhard Schmitz, and W. Fiers p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-κB p65 transactivation mediated by tumor necrosis factor J Biol Chem 273 1998 3285 3290
40. A.C. Wallace, R.A. Laskowski, and J.M. Thornton LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions Prot Eng 8 1995 127 134
41. S.H. Lee, G.S. Seo, and D.H. Sohn Inhibition of lipopolysaccharide induced expression of inducible nitric oxide synthase by butein in RAW 264.7 cells Biochem Biophys Res Comm 323 2004 125 132
42. L. Jeong-Hyung, S.J. Haeng, M.G. Phan, J. Xuejun, L. Sangku, and T.S. Phan Blockade of Nuclear Factor-κB Signaling Pathway and Anti-Inflammatory Activity of Cardamomin, a Chalcone Analog from Alpinia conchigera J Pharmacol Exp Ther 316 2006 271 278
43. A. Paul, A. Cuenda, C.E. Bryant, J. Murray, E.R. Chilvers, and P. Cohen Plevin. R. Involvement of mitogen-activated protein kinase homologues in the regulation of lipopolysaccharide-mediated induction of cyclo-oxygenase-2 but not nitric oxide synthase in RAW 264.7 macrophages Cell Signal 11 1999 491 497
44. Y.W. Lee, S.H. Han, M. Lee, K.H. Yang, H.M. Kim, and Y.J. Jeon 2-Amino-3-methylimidazo[4, 5-f]quinoline inhibits nitric oxide production in lipopolysaccharide-stimulated RAW 264.7 cells by blocking p38 kinase activation Cancer Lett 156 2000 133 139
45. D. Chakravortty, Y. Kato, T. Sugiyama, N. Koide, M.M. Mu, and T. Yoshida The inhibitory action of sodium arsenite on lipopolysaccharide-induced nitric oxide production in RAW 267.4 macrophage cells: A role of Raf-1 in lipopolysaccharide signaling J Immunol 166 2001 2011 2017
46. S. Chen, L. Cao, H.D. Intengan, M. Humphreys, and D.G. Gardner Osmoregulation of endothelial nitric-oxide synthase gene expression in inner medullary collecting duct cells: role in activation of the type a natriuretic peptide receptor J Biol Chem 277 2002 32498 32504
47. K. Tsoyi, H.J. Kim, S. Jae-Soo, K. Dal-Hyun, C. Hee-Jeong, and S.L. Sung HO-1 and JAK-2/STAT-1 signals are involved in preferential inhibition of iNOS over COX-2 gene expression by newly synthesized tetrahydroisoquinoline alkaloid, CKD712, in cells activated with lipopolysacchride Cell Signal 20 2008 1839 1847
48. C.C. Chen, and J.K. Wang p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages Mol Pharmacol 55 1999 481 488
49. A.M. Badger, M.N. Cook, M.W. Lark, T.M. Newman-Tarr, B.A. Swift, and A.H. Nelson SB 203580 inhibits p38 mitogen-activated protein kinase, nitric oxide production, and inducible nitric oxide synthase in bovine cartilage-derived chondrocytes J Immunol 161 1998 467 473
50. J. Da Silva, B. Pierrat, J.L. Mary, and W. Lesslauer Blockade of p38 mitogen activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes J Biol Chem 272 1997 28373 28380
51. K.C. Goh, S.J. Haque, and B.R.G. Williams p38 MAP kinase is required for Stat1 serine phosphorylation and transcriptional activation induced by interferons EMBO J 18 1999 5601 5608
52. H.J. Kim, K. Tsoyi, J.M. Heo, Y.J. Kang, M.K. Park, and Y.S. Lee Regulation of lipopolysaccharide-induced inducible nitric-oxide synthase expression through the nuclear factor-κB pathway and interferon-β/ tyrosine kinase 2/janus tyrosine kinase 2-signal transducer and activator of transcription-1 signaling cascades by 2-naphthylethyl-6,7-dihydroxy-1,2,3,4- tetrahydroisoquinoline (THI 53), a new synthetic isoquinoline alkaloid J Pharmacol Exp Ther 320 2007 782 789
53. N.R. Bhat, and D.L. Feinstein Qin Shen; Bhat, A.N. p38 MAPK-mediated transcriptional activation of inducible nitric-oxide synthase in glial cells J Biol Chem 277 2002 29584 29592
54. J. Won, Y. Im, A.K. Singh, and I. Singh Dual role of cAMP in iNOS expression in glial cells and macrophages is mediated by differential regulation of p38-MAPK/ATF-2 activation and iNOS stability Free Rad Biol Med 37 2004 1834 1844
55. M. Funakoshi-Tago, S. Tanabe, K. Tago, H. Itoh, T. Mashino, and Y. Sonoda Licochalcone A potently inhibits TNFα-induced NF-κB activation through the direct inhibition of IKK activation Mol Pharmacol 76 2009 745 753
56. Z. Cheng, C. Lin, T. Hwang, and C. Teng Broussochalcone A, a potent antioxidant and effective suppressor of inducible nitric oxide synthase in lipopolysaccharide-activated macrophages Biochem Pharmacol 61 2001 939 946
57. M.J. Alcaraz, A.M. Vicente, A. Araico, J.N. Dominguez, M.C. Terencio, and M.L. Ferrandiz Role of nuclear factor-kappaB and heme oxygenase-1 in the mechanism of action of an anti-inflammatory chalcone derivative in RAW 264.7 cells Br J Pharmacol 142 2004 1191 1199
58. S. Hatziieremia, A.I. Gray, V.A. Ferro, A. Paul, and R. Plevin The effects of cardamonin on lipopolysaccharide-induced inflammatory protein production and MAPkinase and NFκB signalling pathways in monocytes/macrophages Br J Pharmacol 149 2006 188 198
59. H.L. Sung, H.S. Dong, Y.J. Xing, W.K. Sang, C.C. Suck, and S.S. Geom 2', 4', 6' Tris(methoxymethoxy) chalcone protects against trinitrobenzene sulfonic acid-induced colitis and blocks tumor necrosis factor-α-induced intestinal epithelial inflammation via heme oxygenase 1-dependent and independent pathways Biochem Pharmacol 74 2007 870 880
60. R.M. Saha, M. Jana, and K. Pahan MAPK p38 regulates transcriptional activity of NF-κB in primary human astrocytes via acetylation of p65 J Immunol 179 2007 7101 7109